Peanut Allergy Overview

Principles

Definition

Peanut allergy is a major research concept in clinical immunology and allergology focused on understanding the specific immune mechanisms responsible for hypersensitivity reactions to peanut proteins. This research investigates etiology, diagnosis, treatment strategies such as immunotherapy, and the public health implications of this prevalent and potentially life-threatening food allergy.

Ontological type

Immunotherapy Strategies

Immunopathogenesis

Diagnostic Approaches

Key developments

Key Figures

IgE Diagnostics and Atopy era

Fernando D. Martínez[1], associated with University of Arizona[3] and Sapienza University of Rome[4] during this era, was a leading figure in advancing IgE-centered diagnostics. His key contribution, evidenced by the 1989 paper 'Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens'[7], demonstrated that serum IgE levels correlate with skin-test reactivity and clinical asthma, underlining the diagnostic value of IgE measurements in this era. S. G. O. Johansson[2], tied to Karolinska Institutet[5] and Uppsala University[6] during this era, contributed foundational work on allergy diagnosis. His 1967 paper 'DIAGNOSIS OF ALLERGY BY AN IN-VITRO TEST FOR ALLERGEN ANTIBODIES'[8] introduced an in vitro assay for allergen antibodies, enabling serum-based diagnostics to complement skin testing and clinical assessment, a pivotal step in IgE-centered diagnostics.

Diagnostic Precision and Epidemiology era

Hugh A. Sampson [1] is a leading allergist affiliated with Johns Hopkins University [3] and the Icahn School of Medicine at Mount Sinai [4] during this era. His key contribution, as reflected in the 2001 paper Utility of food-specific IgE concentrations in predicting symptomatic food allergy [7], was to refine diagnostic precision by correlating specific IgE measurements with clinical reactivity, informing risk stratification in this era. Soheila J. Maleki [2] is a prominent researcher at University of Wisconsin–Madison [5] and the University of Arkansas for Medical Sciences [6] in this era. Her key contribution, highlighted by the 2008 paper Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy [8], integrates epidemiology with preventive strategies by showing early peanut exposure can influence allergy prevalence, guiding population-level recommendations.

Immunotherapy and Early Tolerance era

Aziz Sheikh [1] is a leading scholar associated with Harvard University [3] and the Farr Institute [4] in the Immunotherapy and Early Tolerance era. His key contribution in this era is the EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy [7], which helped standardize practice and safety frameworks. Nikolaos G. Papadopoulos [2] is a prominent figure linked to Johns Hopkins University [5] and Karolinska Institutet [6] in this period. His primary contribution is co-authoring the EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy [7], providing consensus standards that advanced safe, scalable oral immunotherapy approaches during 2014–2023.